YKL-40 IDENTIFIED BY PROTEOMIC ANALYSIS AS A BIOMARKER OF SEPSIS
The DOI matches its Crossref record; 40 of the 42 references it cites were found in a registry or an index.
Abstract
To investigate changes in protein expression by proteomic analysis in the sera of patients with sepsis and to identify new biomarkers of sepsis. A total of 45 consecutive patients with severe sepsis or septic shock (sepsis group), 22 healthy volunteers, and 23 patients undergoing off-pump coronary artery bypass grafting (control group). Serum samples from eight patients of each group underwent proteomic analysis involving removal of 12 major proteins and subsequent reversed-phase high-performance liquid chromatography fractionation and one-dimensional electrophoresis. The intensity of 41 bands (with 12 proteins identified) increased and that of 42 bands (with 22 proteins identified) decreased in the sepsis group. Results of proteomic analysis successfully validated by Western blotting and/or enzyme-linked immunosorbent assay for three proteins (YKL-40, lipocalin 2, and S100A9) increased in the sepsis group as well as two proteins (retinol-binding protein, vitamin D-binding protein) decreased. Serum YKL-40 levels (sYKL-40) on intensive care unit (ICU) admission were assessed by enzyme-linked immunosorbent assay between the two groups; resulting YKL-40 was significantly higher in the sepsis group (P < 0.001). Furthermore, sYKL-40 on ICU admission was significantly higher in patients with positive blood culture (P < 0.005), patients with septic shock (P < 0.05), and patients requiring continuous hemodiafiltration (P < 0.05) or hydrocortisone replacement therapy (P < 0.005) during subsequent treatment. A positive correlation between sYKL-40 and blood IL-6 level on ICU admission was noted in the sepsis group (r = 0.465, P < 0.01). YKL-40 identified by proteomic analysis is considered as a biomarker of sepsis. However, further investigation is needed to clarify its roles and clinical usefulness as a biomarker.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“as is the iron siderophore-binding protein lipocalin-2”
Citations
Cites
APACHE II: A severity of disease classification system
KNAUS, W. A., DRAPER, E. A., WAGNER, D. P., & ZIMMERMAN, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 13,664
APACHE II-A Severity of Disease Classification System: Reply
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,376 · cited 1×
“The Acute Physiology and Chronic Health Evaluation II (14) and Sequential Organ Failure Assessment scores (15) were also calculated on ICU admission.”
MethodBone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Vincent, J.-L., de Mendonca, A., Cantraine, F., Moreno, R., Takala, J., Suter, P. M., Sprung, C. L., Colardyn, F., & Blecher, S. (1998) · Critical Care Medicine · doi:10.1097/00003246-199811000-00016 · Cited by 3,463 · cited 1×
“The Acute Physiology and Chronic Health Evaluation II (14) and Sequential Organ Failure Assessment scores (15) were also calculated on ICU admission.”
MethodSurviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
Dellinger, R. P., Carlet, J. M., Masur, H., Gerlach, H., Calandra, T., Cohen, J., Gea-Banacloche, J., Keh, D., Marshall, J. C., Parker, M. M., et al. (2004) · Intensive Care Medicine · doi:10.1007/s00134-004-2210-z · Cited by 3,321
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
Dellinger, R. P., Carlet, J. M., Masur, H., Gerlach, H., Calandra, T., Cohen, J., Gea-Banacloche, J., Keh, D., Marshall, J. C., Parker, M. M., et al. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000117317.18092.e4 · Cited by 3,018 · cited 1×
“During the ICU stay, patients with severe sepsis or septic shock were treated according to international guidelines (16).”
Dellinger, R. P. (2004) · Critical Care Medicine · Cited by 1,848
Progress with gene‐product mapping of the Mollicutes: Mycoplasma genitalium
Wasinger, V. C., Cordwell, S. J., Cerpa‐Poljak, A., Yan, J. X., Gooley, A. A., Wilkins, M. R., Duncan, M. W., Harris, R., Williams, K. L., & Humphery‐Smith, I. (1995) · ELECTROPHORESIS · doi:10.1002/elps.11501601185 · Cited by 962
Effect of Variation in CHI3L1 on Serum YKL-40 Level, Risk of Asthma, and Lung Function
Ober, C., Tan, Z., Sun, Y., Possick, J. D., Pan, L., Nicolae, R., Radford, S., Parry, R. R., Heinzmann, A., Deichmann, K. A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708801 · Cited by 470 · cited 2×
“First, serum levels of YKL-40 in patients with severe sepsis or septic shock were extremely higher than those in patients with other diseases such as rheumatoid arthritis (22), asthma (23), liver fibrosis (24), Crohn disease (25), acute coronary syndrome (26), and cancer (27).”
BackgroundResultSerum YKL-40, A New Prognostic Biomarker in Cancer Patients?
Johansen, J. S., Jensen, B. V., Roslind, A., Nielsen, D., & Price, P. A. (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0011 · Cited by 339 · cited 2×
“First, serum levels of YKL-40 in patients with severe sepsis or septic shock were extremely higher than those in patients with other diseases such as rheumatoid arthritis (22), asthma (23), liver fibrosis (24), Crohn disease (25), acute coronary syndrome (26), and cancer (27).”
BackgroundResultBoot, R. G., van Achterberg, T. A. E., van Aken, B. E., Renkema, G. H., Jacobs, M. J. H. M., Aerts, J. M. F. G., & de Vries, C. J. M. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.3.687 · Cited by 317 · cited 2×
“Findings such as induction of YKL-40 production by cytokines (32) and the involvement of YKL-40 in tissue remodeling (21) suggest the hypothesis that YKL-40 is secreted as a part of the immune response in repair of tissues injured by invasion of pathogens and immune reaction.”
BackgroundVolck, B., Price, P. A., Johansen, J., Sørensen, O. E., Benfield, T., Nielsen, H. J., Calafat, J., & Borregaard, N. (1998) · PubMed · Cited by 269
Oberholzer, A., Souza, S., Tschoeke, S. K., Oberholzer, C., Abouhamze, A. S., Pribble, J. P., & Moldawer, L. L. (2005) · PubMed · Cited by 219
Rathcke, C. N., & Vestergaard, H. (2006) · Inflammation Research · doi:10.1007/s00011-006-0076-y · Cited by 216 · cited 2×
“Proteomic analysis revealed increased expression of YKL-40 (10) in patients with sepsis.”
BackgroundLiu, T., Qian, W.-J., Mottaz, H. M., Gritsenko, M. A., Norbeck, A. D., Moore, R. J., Purvine, S. O., Camp, D. G., & Smith, R. D. (2006) · Molecular & Cellular Proteomics · doi:10.1074/mcp.t600039-mcp200 · Cited by 208
Epidemiology of Severe Sepsis Around the World
Angus, D., Pires Pereira, C., & Silva, E. (2006) · Endocrine, Metabolic & Immune Disorders-Drug Targets · doi:10.2174/187153006777442332 · Cited by 189 · cited 1×
“6% at 6 months) of severe sepsis/septic shock is lower than those reported in recent review (34).”
ResultFontana, R. J., Goodman, Z. D., Dienstag, J. L., Bonkovsky, H. L., Naishadham, D., Sterling, R. K., Su, G. L., Ghosh, M., & Wright, E. C. (2008) · Hepatology · doi:10.1002/hep.22099 · Cited by 179 · cited 2×
“First, serum levels of YKL-40 in patients with severe sepsis or septic shock were extremely higher than those in patients with other diseases such as rheumatoid arthritis (22), asthma (23), liver fibrosis (24), Crohn disease (25), acute coronary syndrome (26), and cancer (27).”
BackgroundResultInflammatory Cytokines Induce Production of CHI3L1 by Articular Chondrocytes
Recklies, A. D., Ling, H., White, C., & Bernier, S. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m510146200 · Cited by 164 · cited 2×
“Although the reason for the increase in serum level of YKL-40 in sepsis is not yet clear, a recent report that inflammatory cytokines induced production of YKL-40 in neonatal rat articular chondrocytes (32) suggests the possibility of involvement of cytokines produced in association with infection in increase in serum…”
BackgroundHow Shall We Use the Proteomics Toolbox for Biomarker Discovery?
Lescuyer, P., Hochstrasser, D., & Rabilloud, T. (2007) · Journal of Proteome Research · doi:10.1021/pr0702060 · Cited by 161 · cited 1×
“In contrast to tissues, cells, or laboratory animals, human clinical samples tend to exhibit extensive variation in protein profiles determined by proteomic analysis due to the existence of individual differences, which constitute the basis of a recent opposition to proteomic analysis using blood samples (35).”
BackgroundCorticosteroids in Sepsis: From Bench to Bedside?
Annane, D., & Cavaillon, J. (2003) · Shock · doi:10.1097/01.shk.0000079423.72656.2f · Cited by 161 · cited 1×
“Continuous hemodiafiltration (CHDF) and hydrocortisone replacement therapy (50 mg of intravenous hydrocortisone every 6 h) (17) were performed when indicated.”
Tomonaga, T., Matsushita, K., Yamaguchi, S., Oh-Ishi, M., Kodera, Y., Maeda, T., Shimada, H., Ochiai, T., & Nomura, F. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0321 · Cited by 144 · cited 1×
“Western blotting—In parallel with the proteomic analysis described above, Western blotting was performed as described (4, 6), whereas an aliquot of immunoaffinity-subtracted serum sample equivalent to 2 2L of starting serum material was applied to each lane of a commercial acrylamide gel plate, XV PANTERA Gel NXV291HP…”
MethodSelf-citationSaidi, A., Javerzat, S., Bellahcène, A., Vos, J. D., Bello, L., Castronovo, V., Deprez, M., Loiseau, H., Bikfalvi, A., & Hagedorn, M. (2007) · International Journal of Cancer · doi:10.1002/ijc.23313 · Cited by 120 · cited 1×
“Furthermore, a potential relationship between ischemia and increased serum levels of YKL-40 has been suggested by the increase in serum level of YKL-40 reported in human glioblastoma cells transfected with shortinterfering RNAs to suppress expression of vascular endothelial growth factor and thereby artificially induc…”
BackgroundNordenbaek, C., Johansen, J. S., Junker, P., Borregaard, N., Sørensen, O., & Price, P. A. (1999) · The Journal of Infectious Diseases · doi:10.1086/315050 · Cited by 120 · cited 1×
“Elevated levels of YKL40 have been reported in serum of patients with pneumonia (28) and Streptococcus pneumoniae infection (29) as well as in cerebrospinal fluid from patients with purulent meningitis (30).”
BackgroundKirkpatrick, R. B., Emery, J., CONNOR, J., Dodds, R. A., Lysko, P. G., & ROSENBERG, M. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3764 · Cited by 117 · cited 1×
“YKL-40 is secreted by activated macrophages as well (20).”
BackgroundRejman, J. J., & Hurley, W. L. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(88)90524-4 · Cited by 110
Kronborg, G., Østergaard, C., Weis, N., Obel, N., Johansen, J. S., Price, P. A., Nielsen, H., & Pedersen, S. S. (2002) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540110080233 · Cited by 109 · cited 5×
“2%) of 89 patients with pneumonia needed mechanical ventilation in the previous study (29), although 39 (86.”
BackgroundResultInfluentialNishimori, T., Tomonaga, T., Matsushita, K., Oh‐Ishi, M., Kodera, Y., Maeda, T., Nomura, F., Matsubara, H., Shimada, H., & Ochiai, T. (2006) · PROTEOMICS · doi:10.1002/pmic.200500262 · Cited by 104 · cited 1×
“Western blotting—In parallel with the proteomic analysis described above, Western blotting was performed as described (4, 6), whereas an aliquot of immunoaffinity-subtracted serum sample equivalent to 2 2L of starting serum material was applied to each lane of a commercial acrylamide gel plate, XV PANTERA Gel NXV291HP…”
MethodSelf-citationYKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Purulent Meningitis
Østergaard, C., Johansen, J. S., Benfield, T., Price, P. A., & Lundgren, J. D. (2002) · Clinical and Vaccine Immunology · doi:10.1128/cdli.9.3.598-604.2002 · Cited by 103 · cited 1×
“Elevated levels of YKL40 have been reported in serum of patients with pneumonia (28) and Streptococcus pneumoniae infection (29) as well as in cerebrospinal fluid from patients with purulent meningitis (30).”
BackgroundYKL-40 a new biomarker in patients with acute coronary syndrome or stable coronary artery disease
Wang, Y., Ripa, R. S., Johansen, J. S., Gabrielsen, A., Steinbrüchel, D. A., Friis, T., Bindslev, L., Haack‐Sørensen, M., Jørgensen, E. O., & Kastrup, J. (2008) · Scandinavian Cardiovascular Journal · doi:10.1080/14017430802220567 · Cited by 96 · cited 2×
“First, serum levels of YKL-40 in patients with severe sepsis or septic shock were extremely higher than those in patients with other diseases such as rheumatoid arthritis (22), asthma (23), liver fibrosis (24), Crohn disease (25), acute coronary syndrome (26), and cancer (27).”
BackgroundResultA NOVEL SELECTIVE EXTRACORPOREAL INTERVENTION IN SEPSIS
Schefold, J. C., von Haehling, S., Corsepius, M., Pohle, C., Kruschke, P., Zuckermann, H., Volk, H., & Reinke, P. (2007) · Shock · doi:10.1097/shk.0b013e31804f5921 · Cited by 74 · cited 1×
“kines are also considered to be important mediators of sepsis, and modulation of such substances is of therapeutic significance (1).”
BackgroundPeltomaa, R., Paimela, L., Harvey, S., Helve, T., & Leirisalo‐Repo, M. (2001) · Rheumatology International · doi:10.1007/s002960100115 · Cited by 69 · cited 2×
“First, serum levels of YKL-40 in patients with severe sepsis or septic shock were extremely higher than those in patients with other diseases such as rheumatoid arthritis (22), asthma (23), liver fibrosis (24), Crohn disease (25), acute coronary syndrome (26), and cancer (27).”
BackgroundResultShen, Z., Want, E. J., Chen, W., Keating, W., Nussbaumer, W. A., Moore, R., Gentle, T. M., & Siuzdak, G. E. (2006) · Journal of Proteome Research · doi:10.1021/pr060327k · Cited by 66 · cited 2×
“However, only a limited number of reports (8, 9) are available on application of proteomic analysis to clinical samples collected from patients with sepsis, and no results obtained by proteomic analysis for such patients have been fully validated by other well-established analytical techniques.”
BackgroundChanges in the Serum Proteome of Patients with Sepsis and Septic Shock
Kalenka, A., Feldmann, R. E., Otero, K., Maurer, M. H., Waschke, K. F., & Fiedler, F. (2006) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000242533.59457.70 · Cited by 62 · cited 2×
“However, only a limited number of reports (8, 9) are available on application of proteomic analysis to clinical samples collected from patients with sepsis, and no results obtained by proteomic analysis for such patients have been fully validated by other well-established analytical techniques.”
BackgroundCirculating YKL-40 levels during human endotoxaemia
Johansen, J. S., Krabbe, K. S., Møller, K., & Pedersen, B. K. (2005) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2005.02763.x · Cited by 57 · cited 1×
“Increase in plasma YKL-40 in healthy volunteers after injection with Escherichia coli endotoxin has also been reported (31).”
BackgroundErzin, Y. Z., Uzun, H., Karataş, A., & Çelık, A. F. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05121.x · Cited by 56 · cited 2×
“First, serum levels of YKL-40 in patients with severe sepsis or septic shock were extremely higher than those in patients with other diseases such as rheumatoid arthritis (22), asthma (23), liver fibrosis (24), Crohn disease (25), acute coronary syndrome (26), and cancer (27).”
BackgroundResultCoronary Ostial Stenosis: A Complication of Aortic Valve Replacement or Coronary Perfusion?
Björk, V. O., Henze, A. C., & Szamosi, A. (1976) · Scandinavian Journal of Thoracic and Cardiovascular Surgery · doi:10.3109/14017437609167761 · Cited by 36
Zhang, J., Kang, B., Tan, X., Bai, Z., Liang, Y., Xing, R., Shao, J., Xu, N., Wang, R., Liu, S., et al. (2007) · Journal of Proteome Research · doi:10.1021/pr0703425 · Cited by 29
Sogawa, K., Itoga, S., Tomonaga, T., & Nomura, F. (2007) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2006.00282.x · Cited by 24
Self-citationEffect of thyroxine on abnormal pancreatic proteomes of the hypothyroid rdw rat
Satoh, M., Haruta‐Satoh, E., Omori, A., Oh‐Ishi, M., Kodera, Y., FURUDATE, S.-I., & Maeda, T. (2005) · PROTEOMICS · doi:10.1002/pmic.200401117 · Cited by 24 · cited 1×
“and subjected to in-gel tryptic digestion essentially as described previously (13).”
Self-citation
Cited by
Chitinase-3 like-protein-1 function and its role in diseases
Zhao, T., Su, Z., Li, Y., Zhang, X., & You, Q. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00303-7 · Cited by 536
Kell, D. B. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0577-x · Cited by 361
“Note, however, that such methods need careful handling from a statistical point of view (e.g. Altman and Royston 2000; Broadhurst and Kell 2006; Hastie et al. 2001; Ioannidis 2005, 2008).”
BackgroundCommon variants of the vitamin D binding protein gene and adverse health outcomes
Malik, S., Fu, L., Juras, D. J., Karmali, M., Wong, B. Y. L., Gozdzik, A., & Cole, D. E. C. (2013) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2012.750262 · Cited by 151
Mass spectrometry for the discovery of biomarkers of sepsis
Ludwig, K. R., & Hummon, A. B. (2017) · Molecular BioSystems · doi:10.1039/c6mb00656f · Cited by 113
Chitinase-like Proteins are Candidate Biomarkers for Sepsis-induced Acute Kidney Injury
Maddens, B., Ghesquière, B., Vanholder, R. C., Demon, D., Vanmassenhove, J., Gevaert, K., & Meyer, E. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.013094 · Cited by 98
“This is in agreement with increased plasma CHI3L1 concentrations in humans after endotoxin injection (37) and in patients with severe sepsis and septic shock (38).”
BackgroundInfluential
Metadata
- Authors
- Hattori, N., Oda, S., Sadahiro, T., Nakamura, M., Abe, R., Shinozaki, K., Nomura, F., Tomonaga, T., Matsushita, K., Kodera, Y., Sogawa, K., Satoh, M., & Hirasawa, H.
- Affiliations
- Chiba University (JP)
- Kitasato University (JP)
- Chiba University Hospital (JP)
- Corresponding author
- Hattori, Noriyuki
- Oda, Shigeto
- Sadahiro, Tomohito
- Nakamura, Masataka
- Abe, Ryuzo
- Shinozaki, Koichiro
- Hirasawa, Hiroyuki
- ORCID
- Venue
- Shock
- Published
- 2009-10
- Volume
- 32
- Issue
- 4
- Pages
- 393-400
- ISSN
- 1073-2322 (ISSN-L)
- OpenAlex
- W2077667419
- Cited by
- 83
- References
- 42
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 3 · 2023: 6 · 2022: 1 · 2021: 4 · 2020: 4 · 2019: 5 · 2018: 7 · 2017: 1 · 2016: 8 · 2015: 8 · 2014: 5 · 2013: 4 · 2012: 7
- FWCI
- 4.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Shock (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
- Life Sciences › Immunology and Microbiology › Immunology › Biomarkers in Disease Mechanisms
- Keywords
- YKL-40, sepsis, septic shock, serum biomarkers, serum proteome, neutrophil gelatinase-associated lipocalin, S100A9, interleukin-6, hydrocortisone replacement, hemodiafiltration, blood culture, intensive care unit admission
- MeSH terms
- Lipocalin-2, Chitinase-3-Like Protein 1, Acute-Phase Proteins, Aged, Chromatography, High Pressure Liquid, Enzyme-Linked Immunosorbent Assay, Female, Glycoproteins, Humans, Male, Middle Aged, Proto-Oncogene Proteins, Retinol-Binding Proteins, Shock, Septic, Vitamin D-Binding Protein, Blotting, Western, Interleukin-6, Sepsis, Lectins, Calgranulin B, Adipokines, Lipocalins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.